Neurological disease treatment registries and high-quality care monitoring: Improving research and supporting shared decision-making -event

We were proud to host a two-day event on March 21-22, 2025, in Tampere, featuring both a seminar and workshops focused on Neurological Disease Treatment Registries and High-Quality Care Monitoring. The event brought together leading experts, researchers, and healthcare professionals to explore how registries and real-world data can drive research, enhance treatment, and support shared decision-making.

Seminar Highlights:
The role of national health registries in clinical studies and
development of European, Norwegian and Finnish registries for Alzheimer’s and other neurological conditions
The impact of real-world evidence (RWE) on healthcare innovation
Strengthening shared decision-making and patient involvement

 Workshops:
Practical applications of treatment monitoring registries
Nurse and doctor perspectives on shared decision-making and patient-generated data
A huge thank you to all speakers, participants, sponsors, and collaborators for insightful discussions and engaging hands-on sessions!

Together, we continue to advance neurological research and improve patient-centered care.

Merck
Novartis
Bioarctic
Angelini Pharma
StellarQ
Teva
Argenx
Lilly